OClawVPS.com
BrainScope
Edit

BrainScope

http://brainscope.com/
Last activity: 18.06.2025
Active
Categories: CareDiagnosticsHardwareHealthTechMarketMedTechPlatformProductSensorsTechnology
BrainScope® is a medical neurotechnology company that is pioneering the assessment of brain injury, including concussion.
Likes
714
Mentions
33
Location: United States, Maryland, Bethesda
Employees: 11-50
Phone: +1 240-752-7680
Total raised: $18.5M
Founded date: 2006

Investors 3

Funding Rounds 2

DateSeriesAmountInvestors
31.08.2017-$16M-
07.09.2015-$2.5M-

Mentions in press and media 33

DateTitleDescription
18.06.2025The Dawn of Radioligand Therapies: A New Era in Precision OncologyIn the realm of cancer treatment, innovation is the lifeblood that fuels hope. The latest beacon of this hope shines brightly on radioligand therapies (RLTs). These therapies are not just a whisper of potential; they are a clarion call for ...
13.06.2025Indianapolis-based startup leans on connections to treat brain diseasesPlease subscribe to IBJ to decode this article. so" co7tniifn:wct=l l5m=/nne4bBc_omtI"/ioaedel"-_oii=ii0-edidC5a2ru["00-mca5ae=fud othmtwi1ga"e"3r"daletl0ca]nsene d vy.sdstiheip =loto jee6teo mpts m3t [c6i...
06.10.2021BrainScope secures another $35M for commercial expansion of concussion device-
23.03.2021BrainScope Launches Next-Gen Medical Device: First and only FDA-cleared system for true point-of-care assessment of both concussion and brain bleeds now includes Concussion Index
16.02.2021JAMA Highlights Success of BrainScope's EEG-based Concussion Index As Reliable Indicator of Concussion
11.02.2021After a hiatus, Mid-Atlantic Venture Association’s SURGE conference returns Feb. 24 to 26The Mid-Atlantic Venture Association (MAVA) is bringing its SURGE conference back at the end of this month. SURGE is an expansion of the D.C.-based association’s TechBUZZ event and focuses on providing up to 50 early-stage tech startups wit...
25.07.2019BrainScope Surpasses Primary Endpoints in Multi-Year Department of Defense-Funded Validation Study for New Concussion Assessment CapabilityBETHESDA, MD. July 25, 2019 — Brain­Scope announced today that it has suc­cess­ful­ly com­plet­ed a near­ly five year, $9.9 mil­lion U.S. Depart­ment of Defense research con­tract sup­port­ing the devel­op­ment and val­i­da­tion of an objec...
06.05.2019Over 30% Reduction in Unnecessary Head CT Scans When Integrating FDA-Cleared BrainScope OneUse in the Emergency Room demonstrates BrainScope One can reduce patient radiation exposure, decrease use of hospital resources, and shorten throughput times BETHESDA, Md.–(BUSINESS WIRE)–May 6, 2019– BrainScope announced today the publicat...
15.01.2019BrainScope Announces Publication Describing Proprietary Concussion Biomarker to Assess Potential Severity and Predict Prolonged RecoveryFuture Capability Could Aid in Objective Return-to-Activity Decisions BETHESDA, Md.–(BUSINESS WIRE)–January 15, 2019– BrainScope®, a medical neuro-technology company focused on concussion and mild traumatic brain injury (mTBI) assessment, a...
02.01.2019BrainScope Receives FDA Clearance for Multi-Modal, Multi-Parameter Concussion AssessmentNew Concussion-Specific FDA Labeling Adds to Existing BrainScope Claims Complements Multi-Modal Technology Platform and Extensive Intellectual Property Portfolio To Address New Brain and Behavioral Health Conditions BETHESDA, Md.–(BUSINESS ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In